Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anushree Chatterjee

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
ACS Pharmacology & Translational Science|November 14, 2024
Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target OrgansSydney Risen, Sadhana Sharma, Vincenzo S Gilberto, et al.
Frontiers in Chemistry|March 30, 2018
Designing Superoxide-Generating Quantum Dots for Selective Light-Activated NanotherapySamuel M Goodman, Max Levy, Fei-Fei Li, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NF-κB/NLRP3 Translational Inhibition by Nanoligomer Therapy Mitigates Ethanol and Advanced Age-Related NeuroinflammationPaige E Anton, Prashant Nagpal, Julie Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Antagonistic self-sensing and mate-sensing signaling controls antibiotic-resistance transferAnushree Chatterjee, Laura C C Cook, Che-Chi Shu, et al.
Science Advances|October 7, 2017
Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generationColleen M Courtney, Samuel M Goodman, Toni A Nagy, et al.
Communications Biology|March 13, 2021
Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteriaKristen A Eller, Thomas R Aunins, Colleen M Courtney, et al.
Frontiers in Microbiology|April 5, 2018
Spaceflight Modifies <i>Escherichia coli</i> Gene Expression in Response to Antibiotic Exposure and Reveals Role of Oxidative Stress ResponseThomas R Aunins, Keesha E Erickson, Nripesh Prasad, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathyDevin Wahl, Sydney J Risen, Shelby C Osburn, et al.
Journal of Leukocyte Biology|March 4, 2025
Suppression of NF-κB/NLRP3 by nanoligomer therapy mitigates ethanol and advanced age-related neuroinflammationPaige E Anton, Shannon Twardy, Prashant Nagpal, et al.
Journal of Neuroinflammation|July 27, 2024
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathyDevin Wahl, Sydney J Risen, Shelby C Osburn, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
ACS Pharmacology & Translational Science|November 14, 2024
Large- and Small-Animal Studies of Safety, Pharmacokinetics, and Biodistribution of Inflammasome-Targeting Nanoligomer in the Brain and Other Target OrgansSydney Risen, Sadhana Sharma, Vincenzo S Gilberto, et al.
Frontiers in Chemistry|March 30, 2018
Designing Superoxide-Generating Quantum Dots for Selective Light-Activated NanotherapySamuel M Goodman, Max Levy, Fei-Fei Li, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
NF-κB/NLRP3 Translational Inhibition by Nanoligomer Therapy Mitigates Ethanol and Advanced Age-Related NeuroinflammationPaige E Anton, Prashant Nagpal, Julie Moreno, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Antagonistic self-sensing and mate-sensing signaling controls antibiotic-resistance transferAnushree Chatterjee, Laura C C Cook, Che-Chi Shu, et al.
Science Advances|October 7, 2017
Potentiating antibiotics in drug-resistant clinical isolates via stimuli-activated superoxide generationColleen M Courtney, Samuel M Goodman, Toni A Nagy, et al.
Communications Biology|March 13, 2021
Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteriaKristen A Eller, Thomas R Aunins, Colleen M Courtney, et al.
Frontiers in Microbiology|April 5, 2018
Spaceflight Modifies <i>Escherichia coli</i> Gene Expression in Response to Antibiotic Exposure and Reveals Role of Oxidative Stress ResponseThomas R Aunins, Keesha E Erickson, Nripesh Prasad, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathyDevin Wahl, Sydney J Risen, Shelby C Osburn, et al.
Journal of Leukocyte Biology|March 4, 2025
Suppression of NF-κB/NLRP3 by nanoligomer therapy mitigates ethanol and advanced age-related neuroinflammationPaige E Anton, Shannon Twardy, Prashant Nagpal, et al.
Journal of Neuroinflammation|July 27, 2024
Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathyDevin Wahl, Sydney J Risen, Shelby C Osburn, et al.
Pageof 8